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Summary
BANK is an adaptor protein that is highly expressed in
B cells. To investigate its physiological role, we gener-
ated BANK-deficient mice. BANK-deficient mice dis-
played enhanced germinal center formation and IgM
production in response to T-dependent antigens,
whereas this phenotype was blocked in CD40-BANK
double knockout mice. Involvement of BANK in CD40
signaling was further demonstrated by in vitro analy-
sis. CD40-mediated proliferation and survival were
significantly increased in BANK-deficient B cells,
with enhanced Akt activation, whereas introduction
of dominant-negative Akt into BANK-deficient B
cells suppressed the augmented CD40-mediated re-
sponses. Together, our findings suggest that BANKat-
tenuates CD40-mediated Akt activation, thereby pre-
venting hyperactive B cell responses.
Introduction
During T cell-dependent immune responses, B cells rec-
ognize antigens as protein fragments by the B cell anti-
gen receptors (BCRs). This recognition event alone is
not sufficient to fully activate the B cells. Other specific
cell surface molecules expressed on B cells and their li-
gands from antigen-activated T cells serve as a costimu-
latory molecule to induce activation and proliferation of
B cells, thereby promoting cellular differentiation into
antibody-producing plasma cells (Kurosaki, 2002a;
Rajewsky, 1996; Shapiro-Shelef and Calame, 2005).
Among these cognate interactions, the CD40 and
CD40 ligand (CD40L/CD154) system, a member of the
tumor necrosis factor (TNF) superfamily, is well known
to play important roles in such T cell-mediated B cell ac-
tivation (Bishop and Hostager, 2003; Calderhead et al.,
2000; Clark and Craxton, 2003; Quezada et al., 2004).
Indeed, CD40 ligation stimulates B cell survival, pro-
*Correspondence: kurosaki@rcai.riken.jpliferation, differentiation, isotype switching of immuno-
globulin (Ig), and upregulation of surface molecules con-
tributing to antigen presentation (DiSanto et al., 1993;
Fuleihan et al., 1993; Grewal and Flavell, 1998; van Koo-
ten and Banchereau, 1997). In accord with these obser-
vations, mice deficient in either CD40 or CD40L are un-
able to mount a sufficient primary and a secondary
antibody response to T-dependent (TD) antigens and
do not form germinal centers (GCs) (Castigli et al.,
1994; Kawabe et al., 1994; Xu et al., 1994).
Reflecting these multifunctions of CD40 in B cells,
CD40 stimulation evokes multiple signaling pathways.
Among them, the importance of the NF-kB pathway
and its regulatory mechanisms are relatively well known.
The CD40-associated TNF-receptor-associated factors
(TRAFs) TRAF2, TRAF5, and TRAF6 mediate activation
of the NF-kB and JNK pathways (Bishop, 2004; Gram-
mer and Lipsky, 2000). The NF-kB pathway components
of the IkB kinase (IKK) complex, IKKa, IKKb, and IKKg,
and the p50, p52, RelA, c-Rel, and RelB proteins are
thought to be important mediators of CD40-dependent
isotype switching and proliferation. Known signaling
events occurring upon CD40 engagement also include
activation of Lyn, phosphatidylinositol 3-kinase (PI3K),
Akt, ERK, and p38, although the significance of each
event has not been addressed in terms of CD40-medi-
ated biological outcomes (Calderhead et al., 2000;
Grammer and Lipsky, 2000; Ren et al., 1994).
As signaling molecules, in addition to effector en-
zymes, adaptor proteins, which lack intrinsic enzymatic
activity, have emerged to regulate various signaling
events and their biological consequences by recruiting
effector enzymes for integrating or diversifying multiple
pathways (Bishop, 2004; Kurosaki, 2002b; Qian et al.,
2004). BANK, a recently described adaptor molecule,
shares overall structural features with its relatives
BCAP and Dof; they consist of an ankyrin-repeat-like
region and a coiled-coil domain (Battersby et al., 2003;
Yokoyama et al., 2002). Functionally, BANK has been
suggested to participate in BCR-mediated calcium ho-
meostasis through acting on a calcium release channel,
inositol 1,4,5-trisphosphate receptor, but its physiolog-
ical role has not been directly approached (Yokoyama
et al., 2002). To examine its role in B cell development
and activation, we used gene targeting to produce null
mutant mice. Here, we report that BANK functions as
a negative modulator of CD40-mediated Akt activation,
thereby optimizing B cell proliferative and survival re-
sponses.
Results
Expression of BANK in B Lineage Cells
In agreement with the previous observation that BANK is
expressed in B, but not T, lineage cells (Yokoyama et al.,
2002), intracytoplasmic staining of splenocytes by an
anti-BANK antibody revealed that BANK was expressed
in peripheral B cells, but not in CD3+ T cells (Figure 1A).
Furthermore, BANK expression in CD11b+ macro-
phages and CD11c+ dendritic cells could not be
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260Figure 1. Expression of BANK in B Lineage
Cells and Targeting of the BANK Locus
(A) Splenocytes from wild-type (thick solid
lines)andBANK-deficient mice (shaded areas)
were stained with antibodies described in
each FACS profile. Then, cells were fixed, per-
meabilized, and stained with anti-BANK anti-
body or isotype control antibody followed by
flow cytometric analysis. For obtaining immu-
nized splenocytes, wild-type and BANK-
deficient mice were immunized with TNP-
KLH, and spleens were recovered form the
mice on day 7 after immunization. Mean fluo-
rescence intensities of stained cells from
wild-type (black) or BANK-deficient mice
(gray) are indicated in each FACS profiles.
(B) Schematic views of wild-type BANK locus,
targeting vector, and targeted BANK locus are
shown (left). Results of genomic Southern
blotting in ES cells are shown on the right.
(C) Expression of BANK and ERK2 proteins
was analyzed in whole-cell extracts of splenic
B cells from wild-type (+/+) and BANK-
deficient (2/2) mice.detected. Because peripheral B cells are divided into
several subsets based on their developmental stages
or location in peripheral lymphoid organs, we examined
expression of BANK in each subpopulation of peripheral
B cells. Peripheral immature (AA4.1+), mature (AA4.12),
and marginal zone (CD232CD21+) B cells expressed al-
most equal amounts of BANK. Because BANK was dem-
onstrated to affect GC formation as mentioned below
(Figures 2C and 3B), we also examined expression of
BANK in GC B cells from mice immunized with a TD an-
tigen, trinitrophenyl-keyhole limpet hemocyanin (TNP-
KLH). As shown in Figure 1A, expression of BANK in
GC B cells (B220+PNA+) was reduced. These data indi-
cate that BANK is expressed in most of the subpopula-
tions of peripheral B cells but that its expression is de-
creased in GC B cells.
Establishment of BANK-Deficient Mice
To examine the physiological role of BANK in vivo, we
targeted BANK by replacing exon 2 with a neomycin-
resistant cassette (neo) in embryonic stem (ES) cells
and established BANK-deficient mice (Figure 1B). Be-
cause the neo gene is remaining, the possibility that
this remaining gene might affect expression of neigh-
boring genes cannot be completely excluded. Absence
of BANK protein was confirmed by Western blotting on
B cell extracts from the spleen of BANK-deficient mice(Figure 1C). We did not observe any additional bands
in extracts of BANK-deficient B cells, demonstrating
that no aberrant form of BANK is expressed in these
mice.
Flow cytometric analysis of various lymphoid organs
revealed that there were no gross alterations of B cell
development in BANK-deficient mice. Peripheral splenic
B cells can be divided into transitional type 1, 2, 3, ma-
ture, and marginal zone B cells, based on the expression
of AA4.1, IgM, B220, and CD23 as described previously
(Allman et al., 2001). We did not observe differences
in numbers and percentages of transitional type 1
(AA4.1+B220+CD232IgMhi), type 2 (AA4.1+B220+CD23+
IgMhi), type 3 (AA4.1+B220+CD23+IgMlo), and marginal
zone B (AA4.12B220+IgMhiCD232) cells, between wild-
type and BANK-deficient spleens, though slightly in-
creased numbers and percentages of splenic mature B
cells (AA4.12B220+IgMloCD23+), peritoneal B1-a B cells
(CD5+IgMhi), and bone marrow recirculating B cells
(B220hiIgM+) were observed (Figure 2A and Table 1).
This increased number of mature B cells resulted in
the increased ratio of B to T cells in the spleen. Serum
antibody levels were measured by enzyme-linked
immunosorbent assay (ELISA), demonstrating a higher
level of IgG2a, but not other isotypes of Igs, in BANK-
deficient mice (Figure 2B). Histological analysis of
BANK-deficient spleens exhibited increased numbers
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261Figure 2. B Cell Development, GC Formation, and Serum Antibody Titers in BANK-Deficient Mice
(A) Spleens, thymus, peritoneal cavity cells (PEC), and bone marrow cells (BM) were recovered from wild-type (WT) and BANK-deficient (BANK-
KO) mice. Cells were stained with monoclonal antibodies described in panels and subjected to flow cytometric analysis. Average percentages6
SD of B-1a cells in PEC from three mice were 27.6% 6 2.00% in wild-type and 36.7% 6 2.03% in BANK-KO mice, respectively.
(B) Sera were collected from 10- to 12-week-old WT and BANK-KO mice and measured for the concentrations of each Igs isotype by standard
ELISA.
(C) Frozen sections of spleens from WT and BANK-KO mice were stained with FITC-labeled anti-B220 (green) and TRITC-labeled PNA (red). Sec-
tions were analyzed by a confocal microscope. Arrows indicate the location of GCs, cluster of PNA+ cells in B220+ follicle.of spontaneously formed GCs (Figure 2C), which was
also confirmed by flow cytometric analysis (Figure 3A,
unimmunized mice). Collectively, these results indicate
that BANK is dispensable for most aspects of B cell de-
velopment. However, increased numbers in mature B
cells and spontaneous GC B cells, together with a higher
level of IgG2a in BANK-deficient mice, suggest that
BANK might play a negative regulatory role in B cell ho-
meostasis and responses.Enhanced TD Immune Responses
in BANK-Deficient Mice
The increased numbers of spontaneously formed GC
B cells in BANK-deficient mice tempted us to consider
the possibility that BANK might affect immune re-
sponses to exogenously administered antigens. We
found no changes in T cell-independent type II immune
responses as measured by antigen-specific IgM and
IgG3 responses (Figure 3C). However, as shown in
Immunity
262Figure 3. Enhanced GC Formation and IgM Production to TD Antigens in BANK-Deficient Mice
(A) WT and BANK-KO mice were immunized with NP-CGG. Spleens were recovered from mice 7 days after immunization. Splenocytes were
stained with anti-B220 antibody, PNA, and biotynilated-NP-BSA followed by three color flow cytometric analysis.
(B) Spleen frozen sections from WT and BANK-KO mice were made on day 7 after immunization with NP-CGG and were analyzed as done in
Figure 2C.
(C) Mice were immunized with TNP-KLH (top) or TNP-Ficoll (bottom), and sera were collected from the mice at the indicated time. Titers of serum
anti-TNP IgM and IgG antibodies were determined by standard ELISA. Four mice in each genotype were used.
(D) Mice immunized with TNP-KLH were challenged again with the same antigen without adjuvant on day 30 after first immunization. Sera were
collected from the mice on day 7 after second immunization and were measured for the titer of high-affinity anti-TNP IgG1. Five WT and four
BANK-KO mice were used.Figures 3A and 3B, BANK-deficient mice showed en-
hanced GC formation in response to TD antigens. Histo-
logical analysis revealed that the GC numbers in immu-
nized mice were not significantly altered, but the GC size
was enlarged in BANK-deficient mice, compared to
those in wild-type mice (Figure 3B and data not shown).
The TNP-specific IgM, but not IgG1 response after injec-
tion of TNP-KLH, was enhanced (particularly day 14 and
day 21) in BANK-deficient mice (Figure 3C). Though we
observed the increased concentration of IgG2a in unim-
munizaed BANK-deficient mice (Figure 2B), there was
no difference between wild-type and BANK-deficientmice in titers of TNP-specific IgG2a after immunization
of TNP-KLH or TNP-Ficoll (data not shown).
Overall secondary responses to TD antigens were not
altered in BANK-deficient mice; BANK-deficient mice
generated normal amounts of anti-TNP IgG1 after sec-
ondary immunization (data not shown). Moreover, the
amount of anti-TNP IgG1 with higher affinity, as as-
sessed by using TNP2-BSA as a capturing antigen,
was not significantly changed between wild-type and
BANK-deficient mice (Figure 3D). Thus, BANK-deficient
B cells are hyperresponsive in TD primary, but not in
TI-II, responses to antigen in vivo.
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263Enhanced CD40-Mediated Survival and Proliferation
in BANK-Deficient B Cells
To clarify the mechanism underlying the enhanced
humoral immune responses to TD antigens in BANK-
deficient mice, we first examined survival and prolifera-
tion responses of BANK-deficient B cells to various
stimuli in vitro. BANK-deficient B cells exhibited en-
hanced survival to CD40 stimulation, but not to other
stimuli such as anti-IgM, LPS, IL-4, and BAFF (Figure 4A).
This was not due to higher expression of CD40 in BANK-
deficient B cells (Figure 4B). Furthermore, during CD40
stimulation, expression level of BANK was unaltered in
wild-type B cells (Figure 4D).
We also assessed proliferation in response to CD40
stimulation with CFSE-labeled B cells from wild-type
and BANK-deficient mice. As shown in Figure 4C,
BANK-deficient B cells manifested enhanced CD40-me-
diated proliferation. In contrast to effects on survival and
proliferation, expression levels of MHC class II, CD86,
and CD95 molecules were upregulated normally by anti-
CD40 stimulation in the absence of BANK (Figure S1 avail-
able in the Supplemental Data with this article online).
The above in vitro data suggest the possibility that the
enhanced CD40-mediated survival and proliferation
may cause the enhanced TD antigen-specific immune
responses observed in BANK-deficient mice. To test
this hypothesis, we generated BANK-CD40 double
knockout mice and examined TD immune responses.
The hyper-IgM response as well as augmented GC for-
mation observed in BANK-deficient mice were abol-
ished in BANK-CD40 double knockout mice (Figure 4E
and data not shown). These results strongly suggest
that BANK modulates humoral immune responses
through its involvement in CD40-mediated pathways.
Enhanced CD40-Mediated Akt Activation
in BANK-Deficient B Cells
CD40 stimulation in B cells is known to activate multiple
signaling pathways, including NF-kB, MAPKs, and PI3K-
Table 1. Lymphocytes Population in Bank-Deficient Mice
WT BANK2/2
Bone marrow
Pro/pre B cells (B220loIgM2) 6.12 6 1.44 7.16 6 1.30
Immature B cells (B220lo IgM+) 0.803 6 0.140 0.700 6 0.316
Recirculating B cells (B220hiIgM+) 0.938 6 0.170 2.09 6 0.206
Spleen
B cells
T 1 (B220+AA4.1+IgMhiCD232) 0.41 6 0.040 0.49 6 0.11
T2 (B220+AA4.1+IgMhiCD23+) 1.07 6 0.23 1.08 6 0.20
T3 (B220+AA4.1+IgMloCD23+) 1.34 6 0.11 1.45 6 0.16
Mature (B220+AA4.12IgMloCD23+) 17.4 6 1.57 24.0 6 3.17
MZ (B220+AA4.12IgMhiCD232) 1.00 6 0.163 1.29 6 0.423
T cells
CD4+ 12.5 6 1.26 10.1 6 2.39
CD8+ 3.51 6 1.01 3.04 6 1.97
Thymus
CD4+8+ 195 6 6.62 199 6 7.23
CD4+82 20.7 6 3.17 21.9 6 1.78
CD428+ 4.24 6 1.33 4.21 6 1.20
Bone marrow cells were obtained from two femurs. Cell number
(3106) was calculated on the basis of total cell count and flow cyto-
metric analysis. Data are means 6 standard deviation from three
mice. Abbreviation of cell populations are follows: T1, T2, and T3,
transitional type 1, 2, and 3 B cells; MZ, marginal zone B cells.Akt pathways (Calderhead et al., 2000). To determine
which signaling pathways are perturbed in the absence
of BANK, we performed biochemical analysis. Phos-
phorylation status of ERK or JNK by CD40 stimulation
was not significantly altered in BANK-deficient B cells
(Figure 5B). NF-kB activation through both canonical
and noncanonical pathways also seems to operate nor-
mally in the absence of BANK, as judged by phosphory-
lation status of IkBa in the case of canonical pathway
(Figure 5C) and by nuclear translocation of p52 subunit
of NF-kB2 in the case of noncanonical pathway (Fig-
ure 5D). On the other hand, CD40-mediated Akt acti-
vation was significantly enhanced in BANK-deficient B
cells, as assessed by phosphorylation status at Ser473,
a crucial phosphorylation site for Akt activity (Figure 5A).
We also observed slightly increased BCR-mediated Akt
activation though it was less prominent, compared to
CD40-mediated one (Figure 5A).
Having demonstrated the involvement of BANK in
CD40-mediated Akt modulation, we next examined
whether this enhanced CD40-mediated Akt activation
is a major cause for the enhanced CD40-mediated sur-
vival and proliferation in BANK-deficient B cells. For
this purpose, we infected a kinase dead form of Akt1
to BANK-deficient B cells by using lentivirus system
and examined CD40-mediated survival and proliferation
in these B cells. Indeed, this mutant Akt1 suppressed
endogenous Akt activation in a dominant-negative man-
ner, when being overexpressed in fibroblast cells (data
not shown), as described previously (Bois and Grosveld,
2003; Chen et al., 2003; Doronin et al., 2002). As shown in
Figures 6B and 6C, the enhanced CD40-mediated prolif-
eration and survival observed in BANK-deficient B cells
were almost completely abolished by introduction of
a dominant-negative form of Akt1. Collectively, these
data suggest that BANK negatively regulates CD40-me-
diated survival and proliferation through its inhibitory ef-
fect on Akt activation.
Discussion
Although a slightly increased number of splenic mature
B cells was observed in the absence of BANK, overall B
cell development takes place normally in the mutant
mice. This apparently normal B cell development in the
absence of BANK is consistent with the finding that
BANK mutation has no significant effect on BCR- and
BAFF-mediated survival/proliferation and the idea that
BCR and BAFF signaling contributes to maintaining
a mature B cell pool through providing a B cell survival
signal (Lam et al., 1997; Mackay and Browning, 2002;
Meffre et al., 2000; Rajewsky, 1996).
We demonstrate here that, in contrast to BCR and
BAFF signal, CD40-mediated proliferation and survival
are significantly increased in BANK-deficient B cells, im-
plicating a negative or attenuating regulatory role of
BANK in CD40 signaling. These enhanced CD40-medi-
ated responses occurring in B cells appear to, at least
partly, account for the enhanced GC formation and
IgM production in response to TD antigens in BANK-
deficient mice. This idea is supported by three lines of
the following evidence. First, consistent with a previous
report (Yokoyama et al., 2002), BANK was expressed
in B cells but neither T cells nor DC cells (Figure 1A),
Immunity
264Figure 4. Enhanced CD40-Mediated Survival
and Proliferation in BANK-Deficient B Cells
(A) B cells were purified from spleens of WT
and BANK-KO mice and cultured for 48 hr
with anti-IgM antibody (10 mg/ml), human
BAFF (10 mg/ml), anti-CD40 antibody (2 mg/
ml), IL-4 (20 ng/ml), or LPS (5 mg/ml). Cells
were stained with TO-PRO-3 and analyzed
by a FACSCalibur for measuring the percent-
ages of viable TO-PRO-32 cells and dead TO-
PRO-3+ cells. Mean percentages of viable
cells in triplicated culture and SD are shown.
(B) B cells were stained with anti-CD40 (bold
lines) or isotype-matched control antibody
(thin lines) and subjected to flow cytometric
analysis.
(C) B cells purified from spleens were labeled
with CFSE and cultured for 72 hr with indi-
cated stimuli. Cells were subjected to flow cy-
tometric analysis. Percentages of proliferat-
ing cells, judged from reduced fluorescence
intensity, are shown in each FACS profile.
(D) B cells purified from the spleen of WT mice
were cultured for 24 hr with or without 2 mg/ml
of anti-CD40 antibody. RNA was recovered
from cultured B cells of WT mice and sub-
jected to RT-PCR analysis (the numbers of
amplification cycles are shown) as described
in the Experimental Procedures. Cultured B
cells from WT (thick solid lines) or BANK-KO
mice (shaded areas) were also subjected to
flow cytometric analysis as described in
Figure 1A . BANK-KO B cells were similarly
cultured as a negative control for staining.
(E) WT, BANK KO, CD40-deficient (CD40 KO),
and CD40-BANK double-deficient (CD40/
BANK dKO) mice were immunized with
TNP-KLH. Three mice of each genotype
were used. Collected sera were measured
for anti-TNP IgM as described in Figure 3C.demonstrating that this phenotype essentially results
from an intrinsic B cell anomaly. Second, a major func-
tion for CD40 on B cells is to promote humoral immune
responses to TD, but not TI-II, antigens (Castigli et al.,
1994; Kawabe et al., 1994; Xu et al., 1994). In accord
with this fact, TD, but not TI-II, immune responses
were affected in the absence of BANK. Finally, the phe-
notype observed in BANK-deficient mice was sup-
pressed in CD40-BANK double knockout mice. How-
ever, it should be mentioned that the entire phenotype
in BANK-deficient mice might not be attributable to dif-
ferences only in the CD40 signaling pathway. For in-
stance, we observed increased BCR-mediated Akt acti-
vation in BANK-deficient B cells (Figure 5A), possibly
contributing to the phenotype in the mutant mice.
Complete block of CD40 signaling, with establishing
CD40 knockout mice or administrating antagonistic
anti-CD40L antibody to wild-type mice, decreases anti-
gen-specific expansion of B cells and subsequent IgM
production from early phase of TD immune responses(Castigli et al., 1994; Foy et al., 1993; Garside et al.,
1998; Kawabe et al., 1994; Xu et al., 1994) (Figure 4D).
Hence, the relatively late time kinetics of the enhanced
IgM response in BANK-deficient mice (day 14 and day
21 in Figure 3C) are somewhat unexpected. This phe-
nomenon could be explained by the following possibili-
ties. First, only a limited amount of CD40 signal might be
sufficient for initial expansion of antigen-driven B cells
(Sze et al., 2000), whereas a greater amount of CD40 sig-
nal might be required for sustaining the subsequent sur-
vival of the antigen-experienced B cells during TD re-
sponses. Thus, according to this idea, the heightened
CD40 signal might influence the late phase survival
rather than the initial division, which in turn causes the
late kinetics of the enhanced IgM response in BANK-
deficient mice. Second, as demonstrated in Figure 5,
BANK is specifically involved in Akt modulation among
multifaceted CD40 signals. Thus, the augmented Akt
activity in BANK-deficient B cells might play a more
dominant role in prolonging the late phase survival of
Role of BANK in B Cell Activation
265Figure 5. Enhanced CD40-Mediated Akt Ac-
tivation in BANK-KO B Cells
(A–C) Purified B cells from spleens were stim-
ulated with anti-CD40 antibody or anti-IgM
antibody at the indicated time periods.
Wotmannin treatment of cells was done at
100 nM for 10 min before stimulation with
anti-CD40 antibody at 37ºC. Whole-cell ly-
sates from stimulated B cells were subjected
to Western blotting with indicated antibodies.
Average folds increases 6 SD of pAkt (at
10 min after stimulation with 2 mg/ml of anti-
CD40 antibody from three independent ex-
periments) are 7.1 6 1.7 in WT and 9.9 6 1.9
in BANK-KO B cells, respectively.
(D) Purified B cells were cultured for the indi-
cated periods with or without anti-CD40 anti-
body. Cytoplasmic and nuclear fractions of
cell lysates were prepared and subjected to
Western blotting with anti-p100/52 NF-kB2.antigen-experienced B cells in vivo contexts, possibly
explaining the late kinetics of the enhanced IgM re-
sponse.
Several recent reports demonstrate that B cells ex-
pressing surface IgM and IgG have distinct abilities to
transduce signals for proliferation and survival, possibly
by using different signal transduction machineries (Mar-
tin and Goodnow, 2002; Wakabayashi et al., 2002).
Those differences may account for hyper-IgM with a nor-
mal IgG1 response to TD antigens in BANK-deficient
mice (Figure 3C). For instance, IgM-bearing B cells uti-
lize BANK to decrease the signal strength, thereby pre-
venting hyper-IgM responses. By contrast, once B cells
undergo class switching to IgG1, these B cells might be
brought into a less-sensitive state to its inhibitory role.
Alternatively, BANK expression might cease with class
switching to IgG1, thereby making IgG1-bearing B cells
released from the effect of BANK. Additional studies are
underway to define which of the preceding possibilities
is likely.
Although we have now shown that BANK plays a neg-
ative role in CD40-mediated signal, the previous study
showed that overexpression of BANK in transformed
DT40 B cells can augment BCR-induced calcium mobi-
lization (Yokoyama et al., 2002). It is possible that BANK
may play differential functions, depending upon differ-ent receptor systems and/or different cell types. How-
ever, we found that BCR-mediated calcium mobilization
was not significantly changed in both BANK-deficient
primary B cells (Figure S2) and BANK-deficient DT40 B
cells (our unpublished data). Thus, the likely explanation
for this disparity is that the augmented BANK-mediated
calcium mobilization is caused by nonspecific protein-
protein interactions carried out by overexpression of
BANK.
CD40 stimulation is known to evoke multiple signaling
pathways such as NF-kB, MAPKs, and PI3K-Akt path-
ways (Bishop, 2004; Calderhead et al., 2000; Grammer
and Lipsky, 2000; Ren et al., 1994). Hence, it is reason-
able to anticipate that each pathway, either individually
or in combination with another pathway, could play
a unique role in exerting CD40-mediated biological out-
puts. BANK participates in Akt, but not NF-kB signaling,
likely influencing some aspects of the CD40-mediated
biological outputs; GC formation and antigen-specific
IgM production are affected in BANK-deficient mice. In
contrast, we observed that Ig isotype class switch
took place normally in BANK-deficient B cells after being
induced by anti-CD40 Ab together with LPS, IL-4, or
CpG in vitro conditions (data not shown). This seems
to be in good agreement with previous findings that
NF-kB activation participates in isotype class switching
Immunity
266Figure 6. Expression Of Dominant-Negative
Akt Abolishes the Enhanced Cd40-Mediated
Survival and Proliferation of BANK-Deficient
B Cells
Purified splenic B cells were infected with
lentivirus carrying a dominant-negative form
of Akt (Akt kinase dead, Akt k.d.). As a con-
trol, B cells infected with lentivirus without
dominant-negative Akt were also prepared
(Mock). (A) Infection of lentivirus in target
cells was confirmed by the expression of
EGFP. Bold lines and thin lines represent
Akt k.d.-infected cells and noninfected con-
trol cells, respectively. Mock-infected cells
expressed the same level of EGFP as Akt
k.d.-infected cells did (data not shown). In-
fected cells were labeled with CFSE and cul-
tured for 72 hr with or without anti-CD40
antibody. Cell survival (B) and proliferation
(C) were analyzed as described in Figures
4A and 4C. In (B), means 6 SD of triplicated
culture are shown.by inducing germline transcripts (Laurencikiene et al.,
2001; Strom et al., 1999).
Two lines of evidence support the idea that CD40
activates Akt via PI3K. PI3K is indeed activated upon
CD40 engagement, and treatment of wortmannin or
LY294002, an inhibitor for PI3K, completely abolishes
CD40-mediated Akt activation (Figure 5A) (Andjelic
et al., 2000; Ren et al., 1994). Because several reports
suggest a link between CD40 signaling and tyrosine ki-
nase activation (Faris et al., 1994; Ren et al., 1994; Vida-
lain et al., 2000), CD40-mediated PI3K activation might
be initiated through tyrosine phosphorylation. Thus,
two possible mechanisms by which BANK negatively
regulates the PI3K pathway can be envisaged. First,
BANK could act as a feedback attenuator for the PI3K
pathway in CD40 signaling. Tyrosine phosphorylation
of BANK might occur after initial PI3K activation in
CD40 signaling. Indeed, BANK was tyrosine phosphory-
lated upon CD40 engagement (Figure S3). As BANK has
a consensus SH2 binding motif (YxxV) for SHP-2, a SH2
domain-containing tyrosine phosphatase, the phos-
phorylated BANK might recruit and activate SHP-2,
which in turn abrogates the PI3K activation through tyro-
sine dephosphorylation. Second, BANK could exert its
inhibitory role through its interaction with partner pro-
teins by competing with the positive regulators (such
as p85a subunit of PI3K) for the PI3K pathway. In this re-
gard, BCAP could be one of the candidate partner pro-
teins, because this molecule, expressed in B cells, has
four consensus SH2 binding motifs (YxxM) for p85a
(Okada et al., 2000). These mechanisms might operate
also in BCR signaling, given two lines of evidence: (1)
Akt activation is somewhat increased in BANK-deficient
B cells (Figure 5A) and (2) BANK undergoes tyrosine
phosphorylation in BCR signaling (Yokoyama et al.,
2002). Thus, this perturbed BCR signaling in BANK-defi-cient B cells might, at least to some extent, contribute to
the phenotype observed in BANK-deficient mice.
In addition to B cells, CD40 is expressed by a large va-
riety of cell types, including dendritic cells, monocytes,
macrophages, mast cells, and endothelial cells. Mirror-
ing such broad distribution, CD40 is now thought to
function as a general regulator of immune and inflamma-
tory processes rather than a specific regulator for B cell-
mediated responses (Flavell, 2002; Wiley et al., 1997). In-
deed, excess CD40 signaling in mouse models causes
various complex anomalies, leading to diseases, which
include autoantibody production, chronic skin inflam-
mation, and intestinal inflammation (Higuchi et al.,
2002; Kawamura et al., 2004; Mehling et al., 2001). These
anomalies are manifested probably as a net outcome of
multiple cell types. Thus, the identification of BANK as
a B-cell specific negative regulator for CD40 signaling
could provide a tool to dissect such pleiotropic CD40
functions.
Experimental Procedures
Generation of BANK-Deficient Mice
A partialBANK genome clone in pBleo BAC11 vector was purchased
from Genome System. A targeting vector was designed to replace
1.1 kb fragment containing a portion of BANK exon 2 with a neomy-
cin-resistant cassette. The 50 short arm of the targeting vector was
1.0 kb, and the 30 long arm was 8.3 kb. For negative selection, a diph-
theria toxin A cassette was placed at the 50 end of the targeting con-
struct. The Sal I-linealized BANK targeting vector was electropo-
rated into ES cells. ES cells selected by G418 were screened for
the targeted BANK locus by Southern blotting. Eighteen out of 480
ES clones gave the expected size of band for targeted BANK locus.
ES clones that gave the expected size of bands were selected (Fig-
ure 1B) and injected into blastocysts for generating chimeric mice.
Mice and Immunization
CD40-deficient mice were described previously (Kawabe et al.,
1994). All the mice were bred and maintained under SPF conditions
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267at the animal facility of RIKEN Research Center for Allergy and
Immunology. Ten to twelve-week-old mice were used for all ex-
periments. Mice were injected intraperitoneally with 50 mg of TNP-
KLH, 4-hydroxy-3-nitrophenyl-chiken g globulin (NP-CGG) precipi-
tated with alum or 30 mg of TNP-Ficoll. For secondary immunization,
mice were given intraperitoneally 10 mg of TNP-KLH without adju-
vant. All mouse protocols were approved by RIKEN Animal Re-
search Committee.
Antibodies and Other Reagents
A polyclonal anti-mouse BANK antibody was obtained by immuniz-
ing rabbits with bacterially expressed GST-fusion protein containing
amino acid sequences coding mouse BANK (amino acids 500–599).
The isotype control antibody used in Figure 1A is IgG purified from
normal rabbits. The following monoclonal antibodies and reagents
were purchased from BD Bioscience: biotin-anti-CD3, biotin-anti-
CD11c, biotin-anti-CD11b, biotin-anti-B220, biotin-anti-IgM, biotin-
anti-Thy1.2, biotin-anti-NK1.1, biotin-anti-TER119, biotin-anti-Gr1,
FITC-anti-CD23, FITC-anti-CD4, FITC-anti-B220, anti-CD40, PE-
anti-CD8, PE-anti-CD5, PE-streptavidine, APC-streptavidine, FITC-
streptavidine, and magnetic particle-labeled streptavidine. The
following were purchased from Cell Signaling Technology, Inc.:
anti-phospho serine 473 Akt antibody, anti-phospho JNK antibody,
anti-phospho ERK1 2 antibody, and anti-phospho IkBa antibody. All
the antibodies used for ELISA were obtained from Southern Biotech-
nology, Inc. Anti-JNK1, anti-ERK2, and anti-NF-kB2 antibodies were
from Santa Cruz Biotechnology. PE-labeled anti-AA4.1 antibody
was purchased from e-Bioscience. Peanut agglutinin (PNA) was
from Vector Laboratories, Inc. LPS and BAFF were from Sigma
and Peprotech EC., respectively. F(ab0)2 fragments of polyclonal
goat-anti-mouse IgM were purchased from Jackson ImmunoRe-
search Lab. 5-(and 6-) carboxyfluorescein diacetate succinimidyl
ester (CFSE) and TO-PRO-3 were from Molecular Probes.
Immunohistochemistry
Spleens were frozen in OCT compound (Sakura) at 280ºC. Frozen
sections of 8 mm thickness were prepared by using a cryostat. Sec-
tions were fixed with acetone at room temperature for 10 min, then
stained with TRITC-labeled PNA and FITC-labeled anti-B220 anti-
body at room temperature for 1 hr. Stained sections were analyzed
by a confocal microscope (Leica SP2AOBS).
RT-PCR
Purified B cells from spleen of wild-type mice were cultured for 24 hr
with or without 2 mg of anti-CD40 antibody. c-DNAs were prepared
from RNA extracted from cultured cells, then subjected to PCR as
described previously (Yamazaki and Kurosaki, 2003) by using fol-
lowing primers: 50BANK (50-AGCGTCGAAGAACTCGATAATGTTCT
TG-30), 30BANK (50-CAGCAGTGCCTGGTCGTGGTGGCAGCAG-30),
50b actin (50-TGGAATCCTGTGGCATCCATGAAAC-30), and 30b actin
(50-TAAAACGCAGCTCAGTAACAGTCCG-30).
Construction of Lentivirus Vector
Mouse Akt1 cDNA was obtained by RT-PCR method. Mutations were
introduced in Akt1 cDNA by using QuikChange (Stratagene) for re-
placing K179 with a methionine residue, T308, and S473 with alanine
residues to generate a dominant-negative form of Akt1 (Bois and
Grosveld, 2003; Chen et al., 2003; Doronin et al., 2002). The cDNA en-
coding the dominant-negative form of Akt was cloned into pLenti/V5-
DEST (Invitrogen).
ELISA
For measurement of isotype-specific concentrations of Igs, 96-well
ELISA plates (Maxisorp; Nunc) were first coated with 10 mg/ml
of each isotype-specific goat anti-mouse Igs. Blocking was done
in PBS supplemented with 1% BSA. Plates were incubated with
diluted sera followed by incubation of HRP-labeled anti-Igs
antibodies. Plates were then incubated with HRP-substrate,
2,20-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acids), and OD at
405 nm was measured by microplate reader (Model 550; Bio-Rad).
Measurements of TNP-specific IgM and low-affinity IgG1 were car-
ried out in the same protocols as those for isotype-specific Igs, ex-
cept that plates were first coated with TNP23-BSA (10 mg/ml). Formeasurement of high-affinity anti-TNP IgG1, TNP2-BSA was used
for a capturing antigen instead of TNP23-BSA.
Purification and Culture of Cells
For purifying splenic B cells, splenocytes were labeled with cocktail
of biotynilated anti-CD3, Thy1.2, NK1.1, CD11b, and TER119 anti-
bodies followed by incubating with magnetic particle-labeled strep-
tavidine. Unlabeled cells were collected by AutoMACS (Myltenyi
Biotec). More than 95% of resultant cells were B220+ B cells. For la-
beling of cells with CFSE, cells were incubated at 37ºC for 10 min in
RPMI1640 medium containing 5 mM CFSE followed by washing with
RPMI1640 medium containing 10% FCS. Culture was performed
with RPMI1640 medium supplemented with 10% FCS, nonessential
amino acids (100 mM), L-glutamine (2 mM), 2-ME (50 mM), and antibi-
otics. Infection of lentivirus and flow cytometric analysis were car-
ried out as described previously (Oh-hora et al., 2003).
Western Blotting Analysis
Western blotting was performed as described previously (Oh-hora
et al., 2003). Cell lysates from 2 3 106/lane were subjected to West-
ern blotting. For preparing extracts from nuclear and cytoplasm,
NE-PER nuclear and cytoplasmic extraction reagents (Pierce) were
used according to the protocols provided by the manufacturer.
The intensities of corresponding bands were subjected to quantifi-
cation by using a Multi-Gauge software (FujiFilm). Based on these
analyses, the stimulation folds are shown in Figure 5A. All the blot-
ting experiments were repeated at least three times, and represen-
tative results are shown in the figures.
Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.immunity.com/cgi/content/full/24/3/
259/DC1/.
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